Objectives: To test CIDP patients for IgG positivity towards NF186
Samples: 34-45, 48, 68-77, 124-143,18-840 (from Leiden)
Patient ID | Result |
---|---|
34 | - |
35 | - |
36 | - |
37 | - |
38 | - |
39 | - |
40 | - |
41 | - |
42 | - |
43 | - |
44 | - |
45 | - |
48 | - |
68 | - |
69 | - |
70 | - |
71 | - |
72 | - |
73 | - |
74 | - |
75 | - |
76 | - |
77 | - |
124 | - |
125 | - |
126 | - |
127 | - |
128 | - |
129 | - |
130 | - |
131 | - |
132 | - |
133 | - |
134 | - |
135 | - |
136 | - |
137 | - |
138 | - |
139 | weak + |
140 | - |
141 | - |
142 | - |
143 | - |
18-840 | - |
CONTROL - | - |
CONTROL + | + |
- HEKs 293 Cells Transfection: 2018.08.14
- Blocking solution: 5% goat serum in PBS.
- Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
- Primary antibody: AF3235 diluted 1/1000.
- Secondary antibodies: For IgG: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
- Vectashield mounting medium.
RESULTS: Sample 139 is weak positive for IgG towards NF186. The rest of the samples are negative.